200 related articles for article (PubMed ID: 2170560)
1. Identification and characterization of receptors specific for human pancreatic secretory trypsin inhibitor.
Niinobu T; Ogawa M; Murata A; Nishijima J; Mori T
J Exp Med; 1990 Oct; 172(4):1133-42. PubMed ID: 2170560
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the high-affinity receptors on Swiss 3T3 cells which mediate the binding, internalization and degradation of the mitogenic peptide bombesin.
Brown KD; Laurie MS; Littlewood CJ; Blakeley DM; Corps AN
Biochem J; 1988 May; 252(1):227-35. PubMed ID: 2844145
[TBL] [Abstract][Full Text] [Related]
3. EGF receptors in R3230AC rat mammary carcinomas: characteristics and regulation in vitro and in vivo.
Ryan PD; Hilf R
Oncol Res; 1992; 4(4-5):181-92. PubMed ID: 1504378
[TBL] [Abstract][Full Text] [Related]
4. Protamine inhibits platelet derived growth factor receptor activity but not epidermal growth factor activity.
Huang JS; Nishimura J; Huang SS; Deuel TF
J Cell Biochem; 1984; 26(4):205-20. PubMed ID: 6099364
[TBL] [Abstract][Full Text] [Related]
5. Binding of bovine basic pancreatic trypsin inhibitor (Kunitz) as well as bovine and porcine pancreatic secretory trypsin inhibitor (Kazal) to human cathepsin G: a kinetic and thermodynamic study.
Fioretti E; Angeletti M; Coletta M; Ascenzi P; Bolognesi M; Menegatti E; Rizzi M; Ascoli F
J Enzyme Inhib; 1993; 7(1):57-64. PubMed ID: 7510795
[TBL] [Abstract][Full Text] [Related]
6. A specific binding of the cholecystokinin-releasing peptide (monitor peptide) to isolated rat small-intestinal cells.
Yamanishi R; Kotera J; Fushiki T; Soneda T; Saitoh T; Oomori T; Satoh T; Sugimoto E
Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):57-63. PubMed ID: 8471054
[TBL] [Abstract][Full Text] [Related]
7. Competition of a growth stimulating-/cholecystokinin (CCK) releasing-peptide (monitor peptide) with epidermal growth factor for binding to 3T3 fibroblasts.
Fukuoka S; Fushiki T; Kitagawa Y; Sugimoto E; Iwai K
Biochem Biophys Res Commun; 1987 Jun; 145(2):646-50. PubMed ID: 3496093
[TBL] [Abstract][Full Text] [Related]
8. Early events elicited by bombesin and structurally related peptides in quiescent Swiss 3T3 cells. I. Activation of protein kinase C and inhibition of epidermal growth factor binding.
Zachary I; Sinnett-Smith JW; Rozengurt E
J Cell Biol; 1986 Jun; 102(6):2211-22. PubMed ID: 3011811
[TBL] [Abstract][Full Text] [Related]
9. The epidermal growth factor-like domain of recombinant human thrombomodulin exhibits mitogenic activity for Swiss 3T3 cells.
Hamada H; Ishii H; Sakyo K; Horie S; Nishiki K; Kazama M
Blood; 1995 Jul; 86(1):225-33. PubMed ID: 7795228
[TBL] [Abstract][Full Text] [Related]
10. Studies on the pancreatic secretory trypsin inhibitor in plasma and its complex with trypsin in vivo and in vitro.
Eddeland A; Ohlsson K
Scand J Clin Lab Invest; 1978 Oct; 38(6):507-15. PubMed ID: 81511
[TBL] [Abstract][Full Text] [Related]
11. Characterization of specific growth hormone binding sites in mouse fibroblasts.
Murphy LJ; Vrhovsek E; Lazarus L
Endocrinology; 1983 Aug; 113(2):750-7. PubMed ID: 6307651
[TBL] [Abstract][Full Text] [Related]
12. Binding and internalization of transforming growth factor-beta 1 by human hepatoma cells: evidence for receptor recycling.
Sathre KA; Tsang ML; Weatherbee JA; Steer CJ
Hepatology; 1991 Aug; 14(2):287-95. PubMed ID: 1650327
[TBL] [Abstract][Full Text] [Related]
13. Studies on the interaction of Trasylol (aprotinin) with trypsin-pancreatic secretory trypsin inhibitor (PSTI) complexes and with alpha 2-macroglobulin-trypsin-PSTI-complexes.
Marks WH; Eddeland A; Ohlsson K
Hoppe Seylers Z Physiol Chem; 1981 Dec; 362(12):1653-6. PubMed ID: 6172356
[TBL] [Abstract][Full Text] [Related]
14. Receptor-bound somatostatin and epidermal growth factor are processed differently in GH4C1 rat pituitary cells.
Presky DH; Schonbrunn A
J Cell Biol; 1986 Mar; 102(3):878-88. PubMed ID: 2869047
[TBL] [Abstract][Full Text] [Related]
15. Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: binding, internalization, degradation, and biological effects.
Bikfalvi A; Sauzeau C; Moukadiri H; Maclouf J; Busso N; Bryckaert M; Plouet J; Tobelem G
J Cell Physiol; 1991 Oct; 149(1):50-9. PubMed ID: 1719003
[TBL] [Abstract][Full Text] [Related]
16. Bombesin receptor in membranes from Swiss 3T3 cells. Binding characteristics, affinity labelling and modulation by guanine nucleotides.
Sinnett-Smith J; Lehmann W; Rozengurt E
Biochem J; 1990 Jan; 265(2):485-93. PubMed ID: 2154190
[TBL] [Abstract][Full Text] [Related]
17. Platelet-derived growth factor. II. Specific binding to cultured cells.
Bowen-Pope DF; Ross R
J Biol Chem; 1982 May; 257(9):5161-71. PubMed ID: 6279659
[TBL] [Abstract][Full Text] [Related]
18. Binding of the bovine and porcine pancreatic secretory trypsin inhibitor (Kazal) to human leukocyte elastase: a thermodynamic study.
Ascenzi P; Amiconi G; Bolognesi M; Onesti S; Petruzzelli R; Menegatti E
J Enzyme Inhib; 1991; 5(3):207-13. PubMed ID: 1669448
[TBL] [Abstract][Full Text] [Related]
19. Interactions of pancreatic secretory trypsin inhibitor in small intestinal juice: its hydrolysis and protection by intraluminal factors.
Freeman TC; Davies R; Calam J
Clin Chim Acta; 1990 Dec; 195(1-2):27-39. PubMed ID: 2093478
[TBL] [Abstract][Full Text] [Related]
20. Characterization of type I and type II insulin-like growth factor receptors in an intestinal epithelial cell line.
Park JH; Vanderhoof JA; Blackwood D; Macdonald RG
Endocrinology; 1990 Jun; 126(6):2998-3005. PubMed ID: 2161743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
